EUVIMED · CrossrefJournal
The Journal of Pharmacology and Experimental Therapeutics
ISSN 0022-3565 · Elsevier BV
Latest articles
Sirtuin 1-microRNA regulatory networks in liver diseases: Mechanistic convergence, cellular senescence, and translational implications
Allosteric modulator of dopamine transporter inhibits cocaine-induced behaviors in rats
A self-assembling coculture model of retinal fibrosis reveals Bcl-xL inhibitors as cell-selective dual-mechanism antifibrotics
Proteomics-Guided Neurotoxicity Assessment of Zinc-Doped Layered Double Hydroxide Immunoadjuvants versus Free Zn2+
Efficacy of Metformin Nanoparticles in Letrozole-Induced Polycystic Ovarian Rats Exposed to Gamma Radiation: Modulation of TGF-β, α-SMA, AMPK, PPAR-γ, SIRT-1, and FOXO Pathways
Metformin pharmacokinetics in the rat brain: dose- and time-dependent concentrations in reward-relevant regions and differential effects on cocaine locomotor sensitization
Metabolic dysfunction-associated steatohepatitis impairs renal anion transporter function and alters cefazolin pharmacokinetics in mice
Spatiotemporal distribution of paroxetine in the rat brain based on AFADESI-MSI method: impact of simulated weightlessness
Povetacicept Displays Enhanced Serum Exposure and Improved Tissue Distribution Relative to Wild-Type TACI-Fc Molecules
Special Collection: New Therapeutic Targets for Post Traumatic Stress Disorder and Related Sequelae – an editorial
Next-Generation of Hepatitis Therapy Using PDGFRβ Aptamer-Functionalized Rutin Nanocapsules: Preclinical Efficacy and First-in-Human Safety Evaluation
Targeting Adipose Thermogenesis Preserves Cerebral Perfusion and Cognition during Early Metabolic Dysfunction: Functional, Molecular and Proteomic Insights
Ultrasound-Responsive Nanobubbles Synergize Chemo-Immunotherapy for Hepatocellular Carcinoma by Reprogramming the Tumor Microenvironment
MSH2 Activates GOLPH3-Dependent Golgi Dispersal to Promote Irinotecan Resistance in Colorectal Cancer via Enhanced Drug Efflux
Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome
The Role of NR4A1 in Human Disease: Mechanisms, Signalling Pathways, and Therapeutic Potential
Transient receptor potential melastatin 3–dependent disruption of hypothalamic paraventricular nucleus–medial prefrontal cortex serotonergic signaling promotes depressive-like behavior in ovariectomized rats
Peptide–drug conjugates in breast cancer therapy: Emerging targets, translational challenges, and optimization strategies
Chemotype-dependent dissociation of binding affinity and functional potency in synthetic cannabinoids
Adiponectin in cigarette smoke–induced epithelial-mesenchymal transition
Ranolazine inhibits invasiveness of human breast cancer cells in combination with a tyrosine kinase inhibitor: Dose-dependent synergy
A novel drug sequestrant–based therapeutic candidate reverses methamphetamine-induced hyperthermia and hypermetabolism and abates multiorgan toxicity in rats
Δ9-Tetrahydrocannabinol treatment impairs CD8+ T cell differentiation into interferon gamma-competent CD45RO+ cells
Shiheleucel, an allogeneic natural killer cell product expanded under chemically defined conditions, in combination with rituximab-based chemotherapy in relapsed/refractory diffuse large B-cell lymphoma: An exploratory clinical study
Cannabigerol on the brain: Rethinking anxiety, metabolites, and mechanism
SRY-related HMG-box 5 enhances chemosensitivity in esophageal squamous cell carcinoma through toll-like receptor 4/NOD-like receptor family pyrin domain containing 3–mediated pyroptosis
Treating neurological diseases through epigenetic inhibition: A neuroepigenetic therapy hypothesis
Calpeptin and protein kinase C inhibition suppress exosome-associated inflammatory signaling and epidermal dysregulation in a 3-dimensional psoriatic skin model
Olezarsen for the treatment of hypertriglyceridemia: A Bayesian reanalysis of randomized controlled trials
Capsaicin and cinnamaldehyde as topical transient receptor potential vanilloid 1 and transient receptor potential ankyrin 1 agonists in humans: Formulation, stability, and pharmacodynamic evaluation
Volumes
2026 · 1902025 · 8652024 · 7282023 · 7542022 · 1342021 · 1932020 · 2202019 · 2882018 · 2542017 · 2142016 · 2722015 · 3002014 · 3352013 · 3412012 · 4202011 · 5172010 · 5302009 · 5262008 · 5282007 · 5982006 · 7022005 · 6762004 · 6342003 · 6492002 · 6562001 · 6212000 · 6341999 · 7861998 · 7101997 · 7901996 · 8101995 · 8331994 · 8411993 · 8751992 · 7911991 · 5521990 · 9501989 · 7021988 · 7201987 · 677
EUVIMED